LNC
33
-2
MDT
56
-3
NTAP
56
2
PCAR
45
6
WMB
60
-2
RRC
59
4
JPM
53
-4
NDAQ
46
-4
NEM
46
-2
V
52
-6
BIIB
43
4
SIG
38
-2
MAT
49
2
DFS
70
2
DNB
76
-4
FCX
34
4
DHR
49
3
MCD
49
-3
EQT
54
14
DGX
35
2
LNC
33
-2
MDT
56
-3
NTAP
56
2
PCAR
45
6
WMB
60
-2
RRC
59
4
JPM
53
-4
NDAQ
46
-4
NEM
46
-2
V
52
-6
BIIB
43
4
SIG
38
-2
MAT
49
2
DFS
70
2
DNB
76
-4
FCX
34
4
DHR
49
3
MCD
49
-3
EQT
54
14
DGX
35
2
Financhill
Back

Alnylam Pharmaceuticals Vs. Nebius Group NV Industry Stock Comparison

Sell
35

ALNY
Alnylam Pharmaceuticals

Last Price:
$233.21
Seasonality Move:
1.18%
Sell
42

NBIS
Nebius Group NV

Last Price:
$31.18
Seasonality Move:
-3.02%
Sell
35
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $233.15. The Score for ALNY is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
Nebius Group NV (NBIS) is a Sell

Is Nebius Group NV a Buy, Sell or Hold?

  • The current Nebius Group NV [NBIS] share price is $31.22. The Score for NBIS is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • NBIS is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $233.15
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing slight selling pressure.

NBIS Stock Price Chart

What is Nebius Group NV's stock price today?

  • The Nebius Group NV share price today is $31.22
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NBIS is experiencing selling pressure, which indicates risk of future bearish movement.

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -5.72 Sell
Relative Strength Index (14 RSI): 33.95 Sell
Chaikin Money Flow: -189461 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (237.46 - 252.66) Sell
Bollinger Bands (100): (246.78 - 280.66) Sell

NBIS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 1.13 Buy
Relative Strength Index (14 RSI): 59.34 Buy
Chaikin Money Flow: -3309685 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (26.59 - 32.71) Buy
Bollinger Bands (100): (17.22 - 26.82) Buy

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 237.01 Sell
20-day SMA: 243.11 Sell
50-day SMA: 254.57 Sell
200-day SMA: 224.46 Buy
8-day EMA: 236.5 Sell
20-day EMA: 241.8 Sell
50-day EMA: 250.72 Sell
200-day EMA: 234.52 Sell

NBIS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 28.89 Buy
20-day SMA: 30.03 Buy
50-day SMA: 25.12 Buy
200-day SMA: 20.48 Buy
8-day EMA: 29.56 Buy
20-day EMA: 28.7 Buy
50-day EMA: 26.04 Buy
200-day EMA: 21.62 Buy

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.71 per share, and an increase next year of $4.76 per share.

Nebius Group NV Earnings Growth & NBIS Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nebius Group NV Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):